Log in to save to my catalogue

Epidermal growth factor receptor tyrosine kinase‐mediated signalling contributes to diabetes‐induced...

Epidermal growth factor receptor tyrosine kinase‐mediated signalling contributes to diabetes‐induced...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1576192

Epidermal growth factor receptor tyrosine kinase‐mediated signalling contributes to diabetes‐induced vascular dysfunction in the mesenteric bed

About this item

Full title

Epidermal growth factor receptor tyrosine kinase‐mediated signalling contributes to diabetes‐induced vascular dysfunction in the mesenteric bed

Publisher

Oxford, UK: Blackwell Publishing Ltd

Journal title

British journal of pharmacology, 2005-07, Vol.145 (6), p.829-836

Language

English

Formats

Publication information

Publisher

Oxford, UK: Blackwell Publishing Ltd

More information

Scope and Contents

Contents

1
In order to characterize the roles of tyrosine kinases (TKs) and epidermal growth factor receptor (EGFR) in diabetes‐induced vascular dysfunction, we investigated the ability of a chronic administration of genistein, a broad‐spectrum inhibitor of TKs and AG1478, a specific inhibitor of EGFR TK activity to modulate the altered vasoreactivity of...

Alternative Titles

Full title

Epidermal growth factor receptor tyrosine kinase‐mediated signalling contributes to diabetes‐induced vascular dysfunction in the mesenteric bed

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1576192

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1576192

Other Identifiers

ISSN

0007-1188

E-ISSN

1476-5381

DOI

10.1038/sj.bjp.0706238

How to access this item